⚠️ Teaching Case Note: This case has been de-identified and reconstructed for educational purposes. Clinical details reflect real surgical decision-making and outcomes. Patient identity is fully protected.
Septic Shock, ARDS, and Acute Kidney Injury — Rescued in 12 Days
He arrived by emergency ambulance, unresponsive. A 58-year-old man with poorly controlled type 2 diabetes, a decade of hypertension, and a 30-year smoking history — five days of fever and worsening cough had progressed to respiratory failure, then delirium, then collapse. By the time his family called for help, he had been unresponsive for twelve hours.
In the emergency department, his blood pressure was 78/45 mmHg on vasopressors. Heart rate 142. Respiratory rate 32. Oxygen saturation 85% on high-flow mask. qSOFA score: 3 out of 3. The diagnosis was immediate: septic shock with acute respiratory distress syndrome (ARDS).
Twelve days later, he walked out of the ICU.
The Diagnosis: Septic Shock With Three-Organ Failure
Point-of-care ultrasound (POCUS) at the bedside showed inferior vena cava collapsibility below 10% — consistent with volume depletion — with preserved left ventricular ejection fraction (55%) and normal right heart function. PiCCO hemodynamic monitoring confirmed a cardiac index of 2.1 L/min/m², markedly elevated systemic vascular resistance (SVRI 2,800 dyn·s·cm⁻⁵·m²), and an extravascular lung water index of 18 mL/kg — nearly double the upper limit of normal, reflecting severe pulmonary edema.
Inflammatory markers confirmed the severity: CRP 287 mg/L, procalcitonin 45.2 ng/mL, IL-6 1,250 pg/mL, and serum lactate 6.8 mmol/L — indicating profound tissue hypoperfusion. Renal function had deteriorated acutely: creatinine 386 μmol/L against a baseline of 89 μmol/L, with urine output below 0.5 mL/kg/h and arterial pH 7.21.
The clinical picture: septic shock with concurrent moderate ARDS (PaO₂/FiO₂ 120 mmHg) and acute kidney injury requiring renal replacement therapy — three-organ failure from a single infectious source.
Blood cultures grew Klebsiella pneumoniae (ESBL-positive). Sputum cultures identified Pseudomonas aeruginosa (multidrug-resistant). Pro-adrenomedullin (pro-ADM) measured 2.8 nmol/L, consistent with severe bacterial sepsis.
The critical care team — intensive care, infectious disease, clinical pharmacy, nutrition, and rehabilitation — convened immediately. The treatment framework: simultaneous organ support across three systems, early source control, and precision antimicrobial therapy guided by culture results.
Respiratory Support: Lung-Protective Ventilation and Prone Positioning
Mechanical ventilation was initiated in pressure-controlled mode: FiO₂ 100%, peak inspiratory pressure (PIP) 28 cmH₂O, PEEP 12 cmH₂O, respiratory rate 20 breaths per minute. Initial PaO₂/FiO₂ ratio: 120 mmHg — moderate ARDS by Berlin criteria.
Lung-protective ventilation was optimized using driving pressure monitoring (driving pressure = PIP − PEEP). The target: driving pressure below 15 cmH₂O and plateau pressure below 30 cmH₂O. Parameters were adjusted to PIP 24 cmH₂O and PEEP 14 cmH₂O to achieve this.
Prone positioning was initiated within the first 24 hours — 16 hours per day, per current ARDS guidelines. By 72 hours, PaO₂/FiO₂ had improved to 180 mmHg. The patient was successfully extubated on day 5.
Circulatory Support: From Macrocirculation to Microcirculation
Fluid resuscitation in the first three hours comprised 1,000 mL crystalloid plus 20 g albumin, guided by PiCCO parameters rather than fixed-volume protocols. Norepinephrine was titrated to maintain mean arterial pressure at or above 65 mmHg. Vasopressin (0.03 U/min) was added as a catecholamine-sparing agent, reducing norepinephrine requirements and limiting adrenergic toxicity.
Microcirculatory optimization followed the "sepsis cocktail" protocol: intravenous vitamin C 1.5 g every 6 hours, thiamine 200 mg every 12 hours, and hydrocortisone 50 mg every 6 hours. Sublingual video microscopy confirmed progressive improvement in microvascular flow over the first 72 hours — a direct measure of tissue perfusion restoration that standard hemodynamic parameters cannot capture.
Vasopressors were successfully weaned by day 3.
Renal Replacement Therapy: Biomarker-Guided, Citrate-Anticoagulated
Continuous veno-venous hemofiltration (CVVH) was initiated based on three concurrent indications: creatinine rise to 386 μmol/L (4.3× baseline), oliguria persisting beyond 6 hours, and severe metabolic acidosis (pH 7.21). Replacement fluid flow rate was set at 35 mL/kg/h. Regional citrate anticoagulation was selected to minimize systemic bleeding risk in a critically ill patient already on vasopressors.
By day 7, renal function had recovered sufficiently to transition from continuous to intermittent hemodialysis. Inflammatory markers tracked the clinical trajectory throughout: procalcitonin fell from 45.2 to 5.3 ng/mL over 72 hours; lactate normalized from 6.8 to 1.5 mmol/L within the same window.
Antimicrobial Therapy: Empirical First, Then Targeted
Broad-spectrum empirical therapy was initiated within 3 hours of ICU admission: meropenem 1 g every 8 hours plus moxifloxacin 400 mg daily. Blood and sputum cultures were collected before the first antibiotic dose.
At 48 hours, culture and sensitivity results enabled de-escalation to a targeted regimen: ceftazidime-avibactam 2.5 g every 8 hours — active against the ESBL-positive Klebsiella and the MDR Pseudomonas identified. Source control was achieved within 72 hours.
Multidisciplinary Support: Nutrition, Thromboprophylaxis, and Glycemic Control
Enteral nutrition via nasogastric tube was initiated within 24 hours of ICU admission, with prokinetic agents to support gastric motility. Energy target: 25 kcal/kg/day, titrated progressively. Protein target: 1.3 g/kg/day.
Venous thromboembolism prophylaxis combined mechanical compression (intermittent pneumatic compression devices) with pharmacological prophylaxis (low-molecular-weight heparin 40 mg daily, dose-adjusted for renal function). Stress ulcer prophylaxis: pantoprazole 40 mg twice daily. Glycemic control targeted 7.8–10.0 mmol/L via continuous insulin infusion with dynamic glucose monitoring — critical in a patient with pre-existing poorly controlled diabetes.
Early rehabilitation was introduced at 48 hours post-admission: passive range-of-motion exercises progressing to active mobilization as hemodynamic stability allowed.
Outcomes: ICU Day 12, Discharge Day 28
The clinical milestones were sequential and sustained. Vasopressors weaned: day 3. Extubation: day 5. Transition from CVVH to intermittent dialysis: day 7. ICU discharge: day 12. Hospital discharge: day 28.
28-day mortality: 0%.
At 90-day follow-up, SF-36 quality of life assessment showed physical functioning at 75, general health at 68, and mental health at 82 — meaningful recovery across all domains for a patient who had presented in three-organ failure.
His own words: "I have no memory of the first few days. My family told me later how serious it was. What I do remember is waking up and being told, step by step, what had happened and what came next. That clarity — in the middle of the worst experience of my life — made all the difference."
Expert Commentary — Dr. Jieming Qu
"This case reflects three principles that define modern critical care.
First, time-dependence. In sepsis, every hour of delayed treatment increases mortality by approximately 7.6%. Early recognition — using validated tools like qSOFA — and immediate, protocol-driven intervention are non-negotiable. The window for meaningful impact is narrow.
Second, individualized organ support. There is no universal ventilator setting, no fixed fluid volume, no standard CRRT prescription that fits every patient. Driving pressure-guided ventilation, PiCCO-directed fluid management, and biomarker-timed renal replacement therapy all reflect the same principle: support must be calibrated to the individual's physiology, not applied by formula.
Third, multi-dimensional monitoring. Macrocirculatory parameters — blood pressure, cardiac output — are necessary but insufficient. Microcirculatory assessment, cellular metabolic markers, and dynamic inflammatory indices together provide the full picture needed to guide real-time decisions.
This patient's survival reflects the contribution of every team member: the intensivist who recognized the pattern at 3 AM, the pharmacist who optimized the antibiotic dosing, the nutritionist who started feeds within 24 hours, the physiotherapist who began rehabilitation at 48 hours. Sepsis is not a single-specialty disease. It never was."
About Dr. Jieming Qu
Dr. Jieming Qu is Chief of Pulmonary and Critical Care Medicine at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. He specializes in sepsis management, ARDS, and mechanical ventilation in critically ill patients. Dr. Qu is a nationally recognized expert in respiratory critical care and infectious disease, leading multiple national guidelines and clinical research programs in sepsis-induced coagulopathy and organ support strategies.
How CMCS Supported This Patient
China Medical Concierge – Shanghai (CMCS) coordinated the full care pathway: urgent case triage and specialist matching at Ruijin Hospital, ICU admission logistics, on-site Mandarin-English interpretation for family communication throughout the critical care period, daily clinical updates translated for the patient's overseas family members, and post-discharge follow-up coordination including nephrology review, pulmonary rehabilitation scheduling, and 90-day quality of life assessment.
For international patients or expatriate families navigating critical illness in Shanghai — where speed, communication, and specialist access are all life-critical — CMCS provides end-to-end support from emergency triage to long-term recovery.
📧 contract@medicalsh.com | 📱 WhatsApp | 🌐 medicalsh.com
0 commentaire